Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have earned an average rating of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $20.25.

MOBI has been the subject of several analyst reports. The Goldman Sachs Group began coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 price objective for the company. Zacks Research raised Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. JPMorgan Chase & Co. initiated coverage on Mobia Medical in a report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 price objective on the stock. Bank of America began coverage on Mobia Medical in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $16.00 price objective on the stock. Finally, Wolfe Research began coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating for the company.

Insiders Place Their Bets

In other news, major shareholder Osage University Gp Iii, Llc bought 533,333 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the acquisition, the insider directly owned 2,006,716 shares of the company’s stock, valued at $30,100,740. The trade was a 36.20% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Dana G. Jr. Mead bought 7,000 shares of the business’s stock in a transaction on Monday, May 11th. The shares were purchased at an average cost of $15.00 per share, with a total value of $105,000.00. Following the transaction, the director owned 7,000 shares in the company, valued at approximately $105,000. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 1,273,332 shares of company stock valued at $19,088,930 in the last three months.

Mobia Medical Price Performance

NASDAQ MOBI opened at $11.99 on Wednesday. The firm has a market capitalization of $398.66 million, a PE ratio of -0.62 and a beta of 2.84. The company has a 50 day simple moving average of $12.91. Mobia Medical has a 12-month low of $10.19 and a 12-month high of $15.29.

Mobia Medical (NASDAQ:MOBI) last posted its earnings results on Thursday, June 4th. The company reported ($19.30) EPS for the quarter. The business had revenue of $12.07 million for the quarter.